Victory Capital Management Inc. Has $454,000 Stock Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Victory Capital Management Inc. grew its stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 202.2% during the 3rd quarter, Holdings Channel reports. The firm owned 19,298 shares of the company’s stock after buying an additional 12,912 shares during the period. Victory Capital Management Inc.’s holdings in Semler Scientific were worth $454,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. GSA Capital Partners LLP increased its position in shares of Semler Scientific by 73.9% during the 3rd quarter. GSA Capital Partners LLP now owns 10,336 shares of the company’s stock worth $243,000 after purchasing an additional 4,393 shares during the last quarter. Principal Financial Group Inc. acquired a new position in shares of Semler Scientific during the 3rd quarter worth approximately $361,000. US Bancorp DE increased its position in shares of Semler Scientific by 60.8% during the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after purchasing an additional 1,158 shares during the last quarter. Pinnacle Associates Ltd. increased its position in shares of Semler Scientific by 83.9% during the 3rd quarter. Pinnacle Associates Ltd. now owns 29,346 shares of the company’s stock worth $691,000 after purchasing an additional 13,392 shares during the last quarter. Finally, Shariaportfolio Inc. acquired a new position in shares of Semler Scientific during the 3rd quarter worth approximately $3,618,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Stock Down 6.6 %

NASDAQ:SMLR opened at $57.02 on Friday. Semler Scientific, Inc. has a twelve month low of $20.88 and a twelve month high of $79.45. The stock’s 50 day moving average price is $35.16 and its two-hundred day moving average price is $31.74. The firm has a market capitalization of $472.70 million, a price-to-earnings ratio of 28.10 and a beta of 0.92.

Semler Scientific (NASDAQ:SMLR) last issued its earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The company had revenue of $13.51 million during the quarter.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.